Literature DB >> 18719893

Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.

Xiang Yang Zhang1, Lian Yuan Cao, Cai Song, Gui Ying Wu, Da Chun Chen, Ling Yan Qi, Fan Wang, Mei Hong Xiu, Song Chen, Yingyang Zhang, Lin Lu, Therese A Kosten, Thomas R Kosten.   

Abstract

OBJECTIVE: Schizophrenia is associated with various abnormalities in the immune system. Suppression of inflammatory cytokines by cigarette smoke is well-established. The purpose of this study was to determine any differences in cytokine profiles in smokers and nonsmokers with schizophrenia and whether there were any relationships among altered cytokine profiles and psychopathological symptoms.
MATERIALS AND METHODS: Serum interleukin (IL)-2, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha levels were measured in 96 male inpatients with DSM-IV schizophrenia: 66 smokers and 30 nonsmokers. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS).
RESULTS: The positive PANSS symptoms were lower in smokers than nonsmokers, while the negative symptoms were lower in those who smoked more cigarettes. Cytokine levels were positively correlated: IL-2 level with IL-6 and IL-6 with both IL-8 and TNF-alpha. Both IL-2 and IL-6, but not IL-8 or TNF-alpha, were significantly lower in smokers than nonsmokers (p < 0.002; p < 0.01). Lower IL-2 levels correlated with fewer negative symptoms and with smoking more cigarettes.
CONCLUSIONS: The fewer positive symptoms in smokers and fewer negative symptoms in those who smoked more cigarettes may be associated with nicotine-induced suppression of some inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719893     DOI: 10.1007/s00213-008-1295-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

Review 1.  The role of immune function in schizophrenia: an overview.

Authors:  N Müller; M Riedel; M Ackenheil; M J Schwarz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

2.  Serum cytokine concentrations in patients with schizophrenia.

Authors:  I Baker; J Masserano; R J Wyatt
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

3.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

Review 4.  Schizophrenia and nicotinic receptors.

Authors:  R Freedman; L E Adler; P Bickford; W Byerley; H Coon; C M Cullum; J M Griffith; J G Harris; S Leonard; C Miller
Journal:  Harv Rev Psychiatry       Date:  1994 Nov-Dec       Impact factor: 3.732

5.  Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1- versus Th2-type cytokines.

Authors:  N Hallquist; A Hakki; L Wecker; H Friedman; S Pross
Journal:  Proc Soc Exp Biol Med       Date:  2000-07

6.  Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Pei Yan Zhang; Gui Ying Wu; Lian Yuan Cao; Yu Cun Shen
Journal:  Schizophr Res       Date:  2002-10-01       Impact factor: 4.939

7.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

Authors:  L E Adler; L D Hoffer; A Wiser; R Freedman
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

Review 8.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

9.  Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia.

Authors:  H M Xu; J Wei; G P Hemmings
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

10.  Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Lian Yuan Cao; Pei Yan Zhang; Gui Ying Wu; Yu Cun Shen
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

View more
  10 in total

Review 1.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

2.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

3.  Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.

Authors:  Juan A Gallego; Emily A Blanco; Sehba Husain-Krautter; E Madeline Fagen; Paula Moreno-Merino; Juan A Del Ojo-Jiménez; Anthony Ahmed; Thomas L Rothstein; Todd Lencz; Anil K Malhotra
Journal:  Schizophr Res       Date:  2018-07-17       Impact factor: 4.939

4.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

5.  Smoking and Serum Lipid Profiles in Schizophrenia.

Authors:  Hui-Mei An; Yun-Long Tan; Shu-Ping Tan; Jing Shi; Zhi-Ren Wang; Fu-De Yang; Xu-Feng Huang; Jair C Soars; Thomas R Kosten; Xiang-Yang Zhang
Journal:  Neurosci Bull       Date:  2016-03-28       Impact factor: 5.203

Review 6.  Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis.

Authors:  Connor Dunleavy; Richard J Elsworthy; Rachel Upthegrove; Stephen J Wood; Sarah Aldred
Journal:  Acta Psychiatr Scand       Date:  2022-03-05       Impact factor: 7.734

Review 7.  Association of increased prenatal estrogen with risk factors for schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2010-01-06       Impact factor: 9.306

8.  Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia.

Authors:  Furong Zhu; Lulu Zhang; Fang Liu; Renrong Wu; Wenbin Guo; Jianjun Ou; Xiangyang Zhang; Jingping Zhao
Journal:  Front Neurosci       Date:  2018-05-11       Impact factor: 4.677

9.  Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis.

Authors:  Bruno Romeo; Marine Brunet-Lecomte; Catherine Martelli; Amine Benyamina
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

10.  Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China.

Authors:  Hong-Wei Sheng; Hong-Gang Wang; Chun-Zhi Wang; Jiang Wu; Li-Jian Huo; Ruo-Xi Wang; Yong-Jie Zhou; Xiang-Yang Zhang
Journal:  World J Psychiatry       Date:  2022-01-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.